Search results
Tucupita Marcano Officially Banned From MLB For Betting On Games
Fanbuzz· 3 hours agoAfter further investigation, Major League Baseball has banned Padres infielder Tucupita Marcano,...
A Fast-Growing Coffee Chain Is Creating Employment Opportunities for People with Disabilities
Food & Wine via Yahoo News· 5 hours agoThe coffee is hot and strong, there’s ample seating, and the free wifi encourages you to linger. But...
These books offer breezy escapism. That doesn’t mean they’re silly
CNN via Yahoo News· 3 hours agoFrom schools requiring students to read so-called classics in the summer to the anti-racist reading...
The dangers of Red Bull re-signing Perez
Motorsport.com· 2 hours agoA case could be made for it being the wrong move for Red Bull and, indeed, Formula 1, so let's make it. Red Bull has had a dominant enough car that it...
I Saw the TV Glow’s Ending Is Full of Hope, If You Want It to Be
Vulture· 29 minutes agoFor most of my life, I thought I was a character in a TV show. And cis critics have showered the...
With 88% ownership of the shares, Energy Recovery, Inc. (NASDAQ:ERII) is heavily dominated by...
Simply Wall St. via Yahoo Finance· 2 hours agoSo they generally do consider buying larger companies that are included in the relevant benchmark...
Investing in Garmin (NYSE:GRMN) five years ago would have delivered you a 131% gain
Simply Wall St. via Yahoo Finance· 2 hours agoThis EPS growth is reasonably close to the 15% average annual increase in the share price. This...
‘Seinfeld’s’ Michael Richards Speaks Out in 1st TV Interview Since 2006 Racist Rant
Extra TV· 2 hours agoMichael Richards, best known for playing Kramer on “Seinfeld,” was emotional and contrite as he sat...
Las Cruces 'grief party' lightens the load of heavy emotions
Gannett via AOL· 7 hours agoFeaturing a lineup of local poets and musicians, the event was part performance and part therapeutic...
US health experts review MDMA as treatment for PTSD
AFP via Yahoo News· 3 hours agoBut a briefing document put together by the FDA ahead of the meeting suggested its staff were not as convinced.